Varahenage R Perera1, Gerald L Newton, Kit Pogliano. 1. Division of Biological Sciences, University of California at San Diego, 9500 Gilman Drive, Natural Sciences Building 4113, La Jolla, CA 92093-0377, USA.
Abstract
Bacillithiol is a low-molecular-weight thiol analogous to glutathione and is found in several Firmicutes, including Staphylococcus aureus. Since its discovery in 2009, bacillithiol has been a topic of interest because it has been found to contribute to resistance during oxidative stress and detoxification of electrophiles, such as the antibiotic fosfomycin, in S. aureus. The rapid increase in resistance of methicillin-resistant Staphylococcus aureus (MRSA) to available therapeutic agents is a great health concern, and many research efforts are focused on identifying new drugs and targets to combat this organism. This review describes the discovery of bacillithiol, studies that have elucidated the physiological roles of this molecule in S. aureus and other Bacilli, and the contribution of bacillithiol to S. aureus fitness during pathogenesis. Additionally, the bacillithiol biosynthesis pathway is evaluated as a novel drug target that can be utilized in combination with existing therapies to treat S. aureus infections.
Bacillithiol is a low-molecular-weight n class="Chemical">thiol analogous to glutathione and is found in several Firmicutes, including Staphylococcus aureus. Since its discovery in 2009, bacillithiol has been a topic of interest because it has been found to contribute to resistance during oxidative stress and detoxification of electrophiles, such as the antibiotic fosfomycin, in S. aureus. The rapid increase in resistance of methicillin-resistant Staphylococcus aureus (MRSA) to available therapeutic agents is a great health concern, and many research efforts are focused on identifying new drugs and targets to combat this organism. This review describes the discovery of bacillithiol, studies that have elucidated the physiological roles of this molecule in S. aureus and other Bacilli, and the contribution of bacillithiol to S. aureus fitness during pathogenesis. Additionally, the bacillithiol biosynthesis pathway is evaluated as a novel drug target that can be utilized in combination with existing therapies to treat S. aureus infections.
Authors: Zhen Ma; Pete Chandrangsu; Tyler C Helmann; Adisak Romsang; Ahmed Gaballa; John D Helmann Journal: Mol Microbiol Date: 2014-10-07 Impact factor: 3.501
Authors: Ana C Posada; Stacey L Kolar; Renata G Dusi; Patrice Francois; Alexandra A Roberts; Chris J Hamilton; George Y Liu; Ambrose Cheung Journal: Infect Immun Date: 2013-10-28 Impact factor: 3.441
Authors: S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell Journal: Nature Date: 1998-06-11 Impact factor: 49.962
Authors: Vanessa Wiltsie; Skye Travis; Madeline R Shay; Zachary Simmons; Patrick Frantom; Matthew K Thompson Journal: Protein Sci Date: 2021-12-22 Impact factor: 6.725
Authors: Vu Van Loi; Manuela Harms; Marret Müller; Nguyen Thi Thu Huyen; Chris J Hamilton; Falko Hochgräfe; Jan Pané-Farré; Haike Antelmann Journal: Antioxid Redox Signal Date: 2016-08-11 Impact factor: 8.401
Authors: Alberto Guevara-Flores; José de Jesús Martínez-González; Juan Luis Rendón; Irene Patricia Del Arenal Journal: Molecules Date: 2017-02-10 Impact factor: 4.411
Authors: Anzhelika Butenko; Fred R Opperdoes; Olga Flegontova; Aleš Horák; Vladimír Hampl; Patrick Keeling; Ryan M R Gawryluk; Denis Tikhonenkov; Pavel Flegontov; Julius Lukeš Journal: BMC Biol Date: 2020-03-02 Impact factor: 7.431